TumorMAP™ features our innovative and transformational advanced imaging technology to provide on-demand objective insights into cancer margin visualization resected specimens, creating potentially transformative capabilities for intraoperative guidance.
TumorMAP images tissue areas up to 80 mm in size and thus can accept large specimens for analysis. It is powered by our AI-based tissue classification algorithm OncoSIGHT AI™
TumorMAP™ features our innovative and transformational advanced imaging technology to provide on-demand objective insights into cancer margin visualization resected specimens, creating potentially transformative capabilities for intraoperative guidance.
TumorMAP images tissue areas up to 80 mm in size and thus can accept large specimens for analysis. It is powered by our AI-based tissue classification algorithm OncoSIGHT AI™
The Tumor Margin Assessment and Profiling System, TumorMAP™, is a multi-spectral imaging system that uses ultraviolet-excited
The platform offers an intuitive user interface and is seamlessly integrated into the surgical workflow. In addition, the platform provides dynamic information to enable surgeons to visualize tissue previously invisible to them, thus improving the potential for resection success rate of the surgery.!
- Large (32 to 48”) touch screen display
- Ultra High Definition Resolution
- Connectivity to PACS and EMR
- Automated tissue sample tray
- No sample preparation
- Non-destructive to tissue specimens
*TumorMAP™ is not yet cleared for use by the FDA.
See OncoSIGHT in action
>> Move the slider to the left or right to see how OncoSIGHT AI identifies tissue indicative of cancer
OncoSIGHT AI™, is the framework of our digital imaging of cancer/cancer margin technology, leveraging vision-based machine learning in conjunction with the outputs of our advanced optical imaging modalities.
Indication
Pre-clinical research
Feasibility Study
Pivotal Study
FDA Approval
